The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?

被引：1
作者：
Bautista, Jimmy M.
机构：
[1] Univ Santo Tomas Hosp, Gastroenterol Sect, Manila, Philippines
[2] Quirino Mem Med Ctr, Dept Med, Quezon City, Philippines
[3] Jose R Reyes Mem Med Ctr, Dept Surg, Manila, Philippines
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
10.1111/j.1440-1746.2006.04713.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Gastroesophageal reflux disease is a chronic and relapsing disease. Its symptoms do not correlate well with the degree of reflux events or injury that pose a challenge in its management. Thus far, treatment modalities include lifestyle and dietary modifications, antacids and anti-secretory medications, and anti-reflux surgery. With an erratic symptom atology, high cost of treatment, and fear of complications and side effects, the dilemma arises as to when treatment is stopped. Diverse therapeutic strategies continue to advance to address such concerns. The rising trend of on-demand and intermittent proton pump inhibitor therapy has raised various issues regarding efficacy.
引用
收藏
页码：S112 / S114
页数：3
相关论文
共 50 条
[31]   The association between work productivity and response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease [J].
Wahlqvist, P. ;
Ducrotte, P. ;
Jones, R. ;
Liker, H. .
VALUE IN HEALTH, 2006, 9 (06) :A247-A247
[32]   Response of Unexplained Chest Pain to Proton Pump Inhibitor Therapy in Clinical Trials of Gastroesophageal Reflux Disease [J].
Kahrilas, Peter J. ;
Howden, Colin W. ;
Hughes, Nesta .
GASTROENTEROLOGY, 2011, 140 (05) :S580-S580
[33]   Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease [J].
Dal-Paz, K. ;
Moraes-Filho, J. P. ;
Navarro-Rodriguez, T. ;
Eisig, J. N. ;
Barbuti, R. ;
Quigley, E. M. M. .
DISEASES OF THE ESOPHAGUS, 2012, 25 (02) :107-113
[34]   Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy [J].
Kawai, Takashi ;
Hirayama, Yoji ;
Oguchi, Aiko ;
Ishii, Fumi ;
Matushita, Masanao ;
Kitayama, Naoya ;
Morishita, Shinji ;
Hiratsuka, Noboru ;
Ohata, Ken ;
Konishi, Hiroyuki ;
Kishino, Maiko ;
Nakamura, Shinichi .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2017, 60 (02) :143-145
[35]   Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms [J].
Delshad, Sean D. ;
Almario, Christopher V. ;
Chey, William D. ;
Spiegel, Brennan M. R. .
GASTROENTEROLOGY, 2020, 158 (05) :1250-+
[36]   Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease [J].
Tariq, Muhammad Ali ;
Ahmed, Bilal .
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (01) :164-164
[37]   Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease [J].
Yoshikazu Kinoshita ;
Hideaki Kazumori ;
Shunji Ishihara .
Journal of Gastroenterology, 2006, 41 :286-287
[38]   Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease [J].
Kinoshita, Y ;
Kazumori, H ;
Ishihara, S .
JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) :286-287
[39]   Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease [J].
Hillman, L. ;
Yadlapati, R. ;
Whitsett, M. ;
Thuluvath, A. J. ;
Berendsen, M. A. ;
Pandolfino, J. E. .
DISEASES OF THE ESOPHAGUS, 2017, 30 (09) :1-14
[40]   Symptom Predictability in Gastroesophageal Reflux Disease and Role of Proton Pump Inhibitor Test [J].
Estores, David S. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (01) :27-+
12345